Showing 101 - 120 results of 244,701 for search '(( significant based based ) OR ( significant ((we decrease) OR (a decrease)) ))', query time: 3.40s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105

    LSPC treatment decreases neuropathology in prion-infected mice. by Heather Bender (363996)

    Published 2019
    “…<p>Immunohistochemistry (IHC) of brain sections through the (A) cerebellum and (B) hippocampus in infected and uninfected mice reveal that (A) while we observed no difference in cerebellar PrP<sup>Res</sup> accumulation among infected untreated, non-responder or responder mice, both GFAP stain intensity, a measure of astrogliosis, and vacuolation, a hallmark of prion-mediated neurodegeneration, were significantly decreased in LSPC responder mice. …”
  6. 106
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118

    Subgroup analysis of BUN based on pump type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”
  19. 119

    Subgroup analysis of BUN based on surgery type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”
  20. 120

    Column-based Technology for CD9-HPLC Immunoaffinity Isolation of Serum Extracellular Vesicles by Jianhui Zhu (678784)

    Published 2021
    “…Herein we have developed a column-based CD9-antibody-immobilized high-performance liquid chromatography immunoaffinity chromatography­(CD9-HPLC-IAC) technology for EV isolation from a microliter scale of serum for downstream proteomic analysis. …”